Category: Parry
-
![Buying The Dips: Nextech3D.AI (NTAR.C) hits super-value price – why you should be watching]()
Buying The Dips: Nextech3D.AI (NTAR.C) hits super-value price – why you should be watching
Listen, we don’t do buy/sell calls at Equity.Guru, because we’re not your financial advisor and we never want to be in a position where we need to apologize for a bad call. When you buy is down to you, your broker, your advisor, your significant other, your less significant other, and your venegeful god of…
-
![Multi-Company Wrap: Watching the watchlist so you don’t have to]()
Multi-Company Wrap: Watching the watchlist so you don’t have to
We have some 29 companies on our watchlist, all in a variety of sectors, that we’re covering at any one time. Some are clients, some not, some are on deaths door, some are skyrocketing, so we’ve decided to wrap them all up into one monthly wrap so you can keep track of everything at once.…
-
![Pubco cocaine is here: What does it mean, who’s in, and who’s real?]()
Pubco cocaine is here: What does it mean, who’s in, and who’s real?
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl in everything?” I’d asked myself the same question many times – why kill your customers? I’d recommend you go listen because the answer is a lot…
-
![The Core Story: West High Yield Resources (WHY.V) has taken 20 years to be next in line]()
The Core Story: West High Yield Resources (WHY.V) has taken 20 years to be next in line
Part of what makes investing in mining explorers interesting is, you never know when your horse is running. You can trot down to fraser Downs and place a bet on a horse and, when the gates open, it’ll be off and running. Win or lose, at least you know there’s going to be a result.…
-
![The Core Story: Skyharbour Resources (SYH.V) is popping off, like we said it would]()
The Core Story: Skyharbour Resources (SYH.V) is popping off, like we said it would
Over the last few months, we said – repeatedly – that the uranium explorer most likely to get momentum wasn’t the big ones, where the market cap had already run, and wasn’t the tiny ones, where production might be years out, it was the guys in the middle, with plenty of projects, plenty of partners,…
-
![The Core Story: InPlay Oil (IPO.T) riding a sector rise with 6% dividend yield]()
The Core Story: InPlay Oil (IPO.T) riding a sector rise with 6% dividend yield
We liked InPlay Oil a few years back when they said they’d use their debt to grow hard, acquire good oil and gas properties in Alberta, and generate enough revenue (even in lean times) to return funds to shareholders. Many sniffed at that goal, but IPO.T has made it happen, building a cash flow machine…
-
![The Core Story: ARway.AI (ARWY.C) turns consumer navigation into a video game]()
The Core Story: ARway.AI (ARWY.C) turns consumer navigation into a video game
HELPING CUSTOMERS FIND THEIR WAY TO THE CASH REGISTER THE BUSINESS MODEL: ARway offers an AI-driven spatial computing platform for augmented reality (AR) in indoor spaces allowing for superior wayfinding, exhibition design, and customer experience. Their no-code, no-beacon system enables easy creation of digital navigation and AR experiences across devices walking users through a facility…
-
![The Core Story: Beyond Lithium (BY.C) amasses a stonking great lithium portfolio]()
The Core Story: Beyond Lithium (BY.C) amasses a stonking great lithium portfolio
In Ontario, there’s nobody that has a larger stockpile of lithium projects than Beyond Lithium (BY.C). But as a prospect generator, where they differ from many in the space is they’re activdly working the vast majority of those spaces, plumbing a load of the 450 historic holes they lord over, and finding lithium-bearing pegmatites left…
-
![The Core Story: Medexus Pharmaceutical (MDP.T) just grows and grows]()
The Core Story: Medexus Pharmaceutical (MDP.T) just grows and grows
Continuing out Core Story program, today’s exploration is a company we just can’t get enough of, Medexus Pharmaceuticals (MDP.T). CEO Ken D’Entremont has nailed his milestones the last 18 months, continued running revenues up, kept expenses low, and restructured convertible debt to remain in control os his company’s direction going forward. They’ve blasted through a…
-
![The Core Story: Nextech3D.AI (NTAR.C) is where content tech wants to be]()
The Core Story: Nextech3D.AI (NTAR.C) is where content tech wants to be
Equity.Guru presents a new program, the Core Story, featuring Nextech3D.AI. This series dives into the business model, the pros and cons, the numbers and why we think a given company should be interesting to the investor. Sitting smack dab in the middle of the artificial intelligence world, the metaverse, virtual reality and augmented reality, and…
